PARICALCITOL

N/A

Manufactured by AbbVie Inc.

19,271 FDA adverse event reports analyzed

Last updated: 2026-04-14

About PARICALCITOL

PARICALCITOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by AbbVie Inc.. The most commonly reported adverse reactions for PARICALCITOL include DEATH, CARDIAC DISORDER, MYOCARDIAL INFARCTION, SEPSIS, CARDIO-RESPIRATORY ARREST. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PARICALCITOL.

Top Adverse Reactions

DEATH3,570 reports
CARDIAC DISORDER621 reports
MYOCARDIAL INFARCTION584 reports
SEPSIS483 reports
CARDIO RESPIRATORY ARREST476 reports
DYSPNOEA393 reports
CARDIAC FAILURE349 reports
RENAL FAILURE308 reports
PNEUMONIA301 reports
NAUSEA299 reports
CEREBROVASCULAR ACCIDENT285 reports
ASTHENIA276 reports
DIARRHOEA274 reports
VOMITING271 reports
FATIGUE268 reports
CARDIAC ARREST266 reports
PAIN264 reports
INFARCTION258 reports
FALL244 reports
CHRONIC KIDNEY DISEASE236 reports
GENERAL PHYSICAL HEALTH DETERIORATION228 reports
DIZZINESS212 reports
RESPIRATORY ARREST209 reports
INFECTION206 reports
PYREXIA206 reports
ACUTE MYOCARDIAL INFARCTION201 reports
ADVERSE EVENT200 reports
PAIN IN EXTREMITY196 reports
HYPOTENSION192 reports
MALAISE191 reports
HYPERTENSION188 reports
HEADACHE187 reports
CHEST PAIN178 reports
END STAGE RENAL DISEASE175 reports
ABDOMINAL PAIN174 reports
ANAEMIA170 reports
RENAL TRANSPLANT168 reports
CARDIOVASCULAR DISORDER167 reports
OEDEMA PERIPHERAL159 reports
PRURITUS154 reports
PULMONARY OEDEMA144 reports
ARTHRALGIA139 reports
ACUTE KIDNEY INJURY137 reports
GAIT DISTURBANCE135 reports
DEVICE RELATED INFECTION130 reports
DRUG INEFFECTIVE129 reports
UNEVALUABLE EVENT129 reports
NEPHROGENIC SYSTEMIC FIBROSIS123 reports
MOBILITY DECREASED121 reports
NEPHROGENIC ANAEMIA117 reports
HAEMOGLOBIN DECREASED114 reports
DECREASED APPETITE112 reports
RENAL FAILURE CHRONIC111 reports
COUGH110 reports
GASTROINTESTINAL HAEMORRHAGE108 reports
HYPERPARATHYROIDISM SECONDARY108 reports
URINARY TRACT INFECTION107 reports
BLOOD PARATHYROID HORMONE INCREASED103 reports
BACK PAIN102 reports
RASH102 reports
CONSTIPATION101 reports
ANXIETY100 reports
RENAL IMPAIRMENT100 reports
CARDIAC FAILURE CONGESTIVE99 reports
WEIGHT DECREASED98 reports
RESPIRATORY FAILURE97 reports
MUSCULAR WEAKNESS94 reports
ABDOMINAL PAIN UPPER91 reports
HYPOAESTHESIA89 reports
PERITONITIS87 reports
ARRHYTHMIA86 reports
LOSS OF CONSCIOUSNESS86 reports
HYPERCALCAEMIA85 reports
BLOOD CREATININE INCREASED84 reports
SYNCOPE83 reports
OFF LABEL USE80 reports
CALCIPHYLAXIS79 reports
MUSCLE SPASMS78 reports
PLEURAL EFFUSION77 reports
BLOOD PRESSURE INCREASED74 reports
HAEMORRHAGE74 reports
CONDITION AGGRAVATED73 reports
BONE PAIN70 reports
ATRIAL FIBRILLATION69 reports
DEPRESSION69 reports
HIP FRACTURE69 reports
HYPERKALAEMIA69 reports
CORONARY ARTERY DISEASE68 reports
HOSPITALISATION68 reports
SEIZURE68 reports
CONFUSIONAL STATE66 reports
FEELING ABNORMAL66 reports
RESPIRATORY DISTRESS66 reports
RENAL DISORDER65 reports
SKIN INDURATION64 reports
THROMBOSIS64 reports
CEREBROVASCULAR DISORDER62 reports
CHILLS62 reports
SKIN HYPERTROPHY62 reports
DIABETES MELLITUS61 reports

Report Outcomes

Out of 14,024 classified reports for PARICALCITOL:

Serious 90.5%Non-Serious 9.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male7,557 (55.3%)
Female6,007 (44.0%)
Unknown94 (0.7%)

Reports by Age

Age 63201 reports
Age 68183 reports
Age 60182 reports
Age 66167 reports
Age 71162 reports
Age 65161 reports
Age 70159 reports
Age 59158 reports
Age 72157 reports
Age 61154 reports
Age 62154 reports
Age 67154 reports
Age 64153 reports
Age 69147 reports
Age 75144 reports
Age 76144 reports
Age 54143 reports
Age 74142 reports
Age 58141 reports
Age 57140 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with PARICALCITOL?

This profile reflects 19,271 FDA FAERS reports that mention PARICALCITOL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for PARICALCITOL?

Frequently reported terms in FAERS include DEATH, CARDIAC DISORDER, MYOCARDIAL INFARCTION, SEPSIS, CARDIO-RESPIRATORY ARREST, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures PARICALCITOL?

Labeling and FAERS entries often list AbbVie Inc. in connection with PARICALCITOL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.